Article Details
Retrieved on: 2024-12-20 19:55:40
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses Aethlon Medical's Hemopurifier, an investigational device targeting enveloped viruses and extracellular vesicles like exosomes, particularly for H5N1 influenza. It highlights its potential alongside traditional influenza treatments like Oseltamivir and its FDA breakthrough designation.
Article found on: menafn.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here